MedRx Co., Ltd

Notice of Large-Scale Exercise of the 35th Stock Acquisition Rights Issued via Third-Party Allotment (with Exercise Price Adjustment Provisions)

Regarding the 1,522,200 shares issued since the beginning of the month, 15,222 stock options were exercised (10.30% of the total issued 147,820). As of now, unexercised options amount to 64,173 (6,417,300 shares). This notice discloses the specific exercise dates and...

Notice of patent allowance for Bondlido (U.S.)

通知 of U.S. patent allowance for Bondlido. The manufacturing process technology ensuring uniformity and stability of a formulation for treating postherpetic neuralgia (PHN) is protected. The patent term extends to 2040. Considered to contribute to medium- to long-term performance improvement....

Notice of Monthly Exercise Status of the 35th Stock Acquisition Rights issued through a Third-Party Allotment (exercise price adjustment clause)

Disclosure of the July monthly exercise status of the 35th stock acquisition rights allocated to Growth Capital. The number of issued shares is 5,936,500 shares; stock acquisition rights exercised in July total 59,365 units (40.16% of issued shares), with 7,939,500...

Notice Regarding the Large-Scale Exercise of Stock Acquisition Rights Issued Through Third-Party Allotment with Exercise Price Adjustment Clause (2023)

Notice Regarding Large-Scale Exercise of the 35th Warrants with Exercise Price Adjustment Clause Issued Through a Third-Party Allocation